BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maiese K. Prospects and Perspectives for WISP1 (CCN4) in Diabetes Mellitus. Curr Neurovasc Res 2020;17:327-31. [PMID: 32216738 DOI: 10.2174/1567202617666200327125257] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu L, Xu S, Li P, Li L. A novel adipokine WISP1 attenuates lipopolysaccharide-induced cell injury in 3T3-L1 adipocytes by regulating the PI3K/Akt pathway. Obes Res Clin Pract 2022;16:122-9. [PMID: 35431155 DOI: 10.1016/j.orcp.2022.03.001] [Reference Citation Analysis]
2 Maiese K. The Mechanistic Target of Rapamycin (mTOR): Novel Considerations as an Antiviral Treatment. Curr Neurovasc Res 2020;17:332-7. [PMID: 32334502 DOI: 10.2174/1567202617666200425205122] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
3 Maiese K. Nicotinamide as a Foundation for Treating Neurodegenerative Disease and Metabolic Disorders. Curr Neurovasc Res 2021;18:134-49. [PMID: 33397266 DOI: 10.2174/1567202617999210104220334] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Maiese K. Cognitive Impairment and Dementia: Gaining Insight through Circadian Clock Gene Pathways. Biomolecules 2021;11:1002. [PMID: 34356626 DOI: 10.3390/biom11071002] [Reference Citation Analysis]
5 Maiese K. Nicotinamide: Oversight of Metabolic Dysfunction Through SIRT1, mTOR, and Clock Genes. Curr Neurovasc Res 2020;17:765-83. [PMID: 33183203 DOI: 10.2174/1567202617999201111195232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]